Literature DB >> 30430668

Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.

Marianne Engels1, Claire Michael2, Katalin Dobra3, Anders Hjerpe3, Ambrogio Fassina4, Pinar Firat5.   

Abstract

Serous effusion fluid is one of the most commonly encountered specimens in routine cytopathology practice. It provides invaluable information about the patient and the clinical status; but to get the most of it, specimen handling and processing must be carried out properly. Cytomorphology is the basis of a successful analysis which should complemented by ancillary tests when needed. A wide spectrum of ancillary techniques - ranging from immunocytochemistry and flow cytometry to different assays of molecular pathology - can be applied to serous effusions. This article describes the acquisition and management of serous effusion fluids, methods for preservation and transportation, different techniques of cytopreparation, application of immunocytochemistry, flow cytometry, and fluorescence in-situ hybridization (FISH), as well as DNA extraction for polymerase chain reaction (PCR) and next generation sequencing (NGS). Principles of bio-banking of effusion samples are also discussed which is getting more important in correlation with the developments in personalized medicine.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  bio-banking; effusion cytology; fluorescence in situ hybridisation; immunocytochemistry; molecular tests; preparation techniques; serous effusion

Mesh:

Year:  2019        PMID: 30430668     DOI: 10.1111/cyt.12654

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer.

Authors:  Jiaxue He; Xintong Hu; Liguo Chen; Qiaoliang Liu; Yanfang Jiang
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

Review 2.  Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.

Authors:  Georgia Ι Grigoriadou; Stepan M Esagian; Han Suk Ryu; Ilias P Nikas
Journal:  J Pers Med       Date:  2020-11-01

3.  Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.

Authors:  Ilias P Nikas; Cheol Lee; Min Ji Song; Bohyun Kim; Han Suk Ryu
Journal:  Cancer Med       Date:  2022-02-25       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.